BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong X, Gong Y, Zeng H, Hao Y, Wang X, Hou J, Wang J, Li J, Zhu Y, Liu H. Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure. Liver Int. 2013;33:1517-1526. [PMID: 23869954 DOI: 10.1111/liv.12248] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Jeffery HC, Braitch MK, Brown S, Oo YH. Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives. Front Immunol 2016;7:334. [PMID: 27656181 DOI: 10.3389/fimmu.2016.00334] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
2 Qiao CY, Li F, Teng Y, Zhao J, Hu N, Fan YC, Wang K. Aberrant GSTP1 promoter methylation predicts poor prognosis of acute-on-chronic hepatitis B pre-liver failure. Clin Exp Med 2018;18:51-62. [PMID: 28676943 DOI: 10.1007/s10238-017-0466-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
3 Ye C, Li W, Li L, Zhang K. Glucocorticoid Treatment Strategies in Liver Failure. Front Immunol 2022;13:846091. [PMID: 35371046 DOI: 10.3389/fimmu.2022.846091] [Reference Citation Analysis]
4 Chen P, Wang YY, Chen C, Guan J, Zhu HH, Chen Z. The immunological roles in acute-on-chronic liver failure: An update. Hepatobiliary Pancreat Dis Int 2019;18:403-11. [PMID: 31303562 DOI: 10.1016/j.hbpd.2019.07.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
5 Jin L, Wang K, Liu H, Chen T, Yang Y, Ma X, Wang J, Li Y, Du D, Zhao Y, He Y. Genomewide Histone H3 Lysine 9 Acetylation Profiling in CD4+ T Cells Revealed Endoplasmic Reticulum Stress Deficiency in Patients with Acute‐on‐chronic Liver Failure. Scand J Immunol 2015;82:452-9. [DOI: 10.1111/sji.12341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
6 Lu ZH, Huang XP, Sun W, Zhu YL, Cui JJ, Chen W, Huang LH, Kuai SG, Du HJ, Ju ZX, Gan JH. T helper cell dysregulation with hepatitis B and rebalance with glucocorticoids. World J Gastroenterol 2014; 20(48): 18354-18359 [PMID: 25561802 DOI: 10.3748/wjg.v20.i48.18354] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
7 Sun FK, Wang K. Application of glucocorticoids in liver failure. Shijie Huaren Xiaohua Zazhi 2015; 23(29): 4611-4616 [DOI: 10.11569/wcjd.v23.i29.4611] [Reference Citation Analysis]
8 Wang F, Sun W, Xiao Q, Liang C, Jiang S, Lian Y, Shao J, Tan S, Zheng S. Peripheral T lymphocytes predict the severity and prognosis in patients with HBV-related acute-on-chronic liver failure. Medicine (Baltimore) 2021;100:e24075. [PMID: 33592861 DOI: 10.1097/MD.0000000000024075] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Dietze KK, Schimmer S, Kretzmer F, Wang J, Lin Y, Huang X, Wu W, Wang B, Lu M, Dittmer U. Characterization of the Treg Response in the Hepatitis B Virus Hydrodynamic Injection Mouse Model. PLoS One. 2016;11:e0151717. [PMID: 26986976 DOI: 10.1371/journal.pone.0151717] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
10 Qiang R, Liu X, Xu J. The Immune Pathogenesis of Acute-On-Chronic Liver Failure and the Danger Hypothesis. Front Immunol 2022;13:935160. [DOI: 10.3389/fimmu.2022.935160] [Reference Citation Analysis]
11 Li J, Hu CH, Chen Y, Zhou MM, Gao ZJ, Fu MJ, Wang J, Li JZ, Chen TY, Zhao YR, He YL. Characteristics of Peripheral Lymphocyte Subsets in Patients With Acute-On-Chronic Liver Failure Associated With Hepatitis B. Front Med (Lausanne) 2021;8:689865. [PMID: 34386507 DOI: 10.3389/fmed.2021.689865] [Reference Citation Analysis]
12 Li Y, Kong Y, Shi K, Huang Y, Zhang Q, Zhu B, Zeng H, Wang X. CD200R Combined Neutrophil-Lymphocyte Ratio Predict 90-Day Mortality in HBV-Related Acute-On-Chronic Liver Failure. Front Med (Lausanne) 2021;8:762296. [PMID: 34938747 DOI: 10.3389/fmed.2021.762296] [Reference Citation Analysis]
13 Asrani SK, Simonetto DA, Kamath PS. Acute-on-Chronic Liver Failure. Clin Gastroenterol Hepatol 2015;13:2128-39. [PMID: 26188138 DOI: 10.1016/j.cgh.2015.07.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
14 Melgaço JG, Soriani FM, Sucupira PHF, Pinheiro LA, Vieira YR, de Oliveira JM, Lewis-Ximenez LL, Araújo CCV, Pacheco-Moreira LF, Menezes GB, Cruz OG, Vitral CL, Pinto MA. Changes in cellular proliferation and plasma products are associated with liver failure. World J Hepatol 2016; 8(32): 1370-1383 [PMID: 27917263 DOI: 10.4254/wjh.v8.i32.1370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Zhou X, Li Y, Ji Y, Liu T, Zhao N, He J, Yao J. PD-1 Involvement in Peripheral Blood CD8+ T Lymphocyte Dysfunction in Patients with Acute-on-chronic Liver Failure. J Clin Transl Hepatol 2021;9:283-90. [PMID: 34221914 DOI: 10.14218/JCTH.2020.00142] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Kondo Y, Shimosegawa T. Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs. Int J Mol Sci 2015;16:3307-22. [PMID: 25654227 DOI: 10.3390/ijms16023307] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
17 Li W, Han J, Wu H. Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression. Chronic Dis Transl Med 2016;2:67-80. [PMID: 29063027 DOI: 10.1016/j.cdtm.2016.09.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
18 Shen G, Sun S, Huang J, Deng H, Xu Y, Wang Z, Tang X, Gong X. Dynamic changes of T cell receptor repertoires in patients with hepatitis B virus-related acute-on-chronic liver failure. Hepatol Int. 2020;14:47-56. [PMID: 31872330 DOI: 10.1007/s12072-019-10008-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
19 Busca A, Kumar A. Innate immune responses in hepatitis B virus (HBV) infection. Virol J. 2014;11:22. [PMID: 24507433 DOI: 10.1186/1743-422x-11-22] [Cited by in Crossref: 79] [Cited by in F6Publishing: 49] [Article Influence: 9.9] [Reference Citation Analysis]
20 Wan Z, Xie G, Wu Y, Liu F, Xin S, You S, Liu H, Li C, Li D. Cytokines elevated in patients with HBV-related acute-on-chronic liver failure promote NK cell mediated cytotoxicity through TRAIL. Dig Liver Dis 2016;48:528-35. [PMID: 26860239 DOI: 10.1016/j.dld.2016.01.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
21 Selvapatt N, Singanayagam A, Wendon J, Antoniades CG. Understanding infection susceptibility in patients with acute-on-chronic liver failure. Intensive Care Med. 2014;40:1363-1366. [PMID: 24902795 DOI: 10.1007/s00134-014-3349-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
22 Gustot T. Beneficial role of G-CSF in acute-on-chronic liver failure: effects on liver regeneration, inflammation/immunoparalysis or both? Liver Int. 2014;34:484-486. [PMID: 24612170 DOI: 10.1111/liv.12356] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
23 Tan NH, Chen B, Peng J, Du S. Treg/Th17 Cell Balance in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure at Different Disease Stages. Biomed Res Int 2021;2021:9140602. [PMID: 34869773 DOI: 10.1155/2021/9140602] [Reference Citation Analysis]